Skip to content

Good Bowls: Eat Well At Work

Phase II (Intervention): Good Bowls: Empowering Communities to Achieve Good Food Access and Health Equity

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05776303
Acronym
EWAW
Enrollment
201
Registered
2023-03-20
Start date
2023-03-15
Completion date
2025-07-31
Last updated
2026-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior, Eating, Nutrition, Healthy

Keywords

Med-South Diet, Worksite Intervention, Subsidized Food, App-based Messaging

Brief summary

The goal of this clinical trial is to improve the health of workers at their worksite by providing subsidized healthy meals supported by nutrition education and behavioral nudges using mobile health and Bluetooth technology. The aim of this study is to: Randomize 240 individuals in 8-10 worksites to either Good Bowls alone or Good Bowls + Phone App nudges. Using a crossover design, the primary outcome is the score on a validated Mediterranean diet screener, with secondary outcomes including weight, blood pressure, carotenoid levels, and food security. Participants: Workers at blue and white-collar worksites. Procedures: Workers will be recruited from 8-10 worksites who will be initially randomized within each site to Good Bowls alone or Good Bowls + Phone App nudges. Initial assignment will be followed for four months, after which the groups will crossover for the subsequent four months. The investigators will collect survey data as well as some physiologic measures including skin scanning (non-invasive), weight, and blood pressure. Effects between groups will be determined.

Interventions

BEHAVIORALGood Bowls

Healthy, frozen subsidized meals are made conveniently available on worksites.

BEHAVIORALGood Bowls + App Nudges

Healthy, frozen subsidized meals are made conveniently available on worksites. Additionally, Bluetooth enabled beacons will be set up at each worksite that will send location specific messages to an individual's Smartphone via an App. These messages will include nutritional information, tips, and behavioral nudges.

Sponsors

Equiti Food, LLC
Lead SponsorINDUSTRY
National Institutes of Health (NIH)
CollaboratorNIH
University of North Carolina, Chapel Hill
CollaboratorOTHER
University of North Carolina, Greensboro
CollaboratorOTHER
North Carolina State University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomize 240 individuals in 8-10 worksites to either Good Bowls alone or Good Bowls + Phone App nudges at a 1:1 allocation ratio. Initial assignment will be followed for four months, after which the groups will crossover for the subsequent four months.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Employed at participating worksite * No plans to move from the area for at least 1 year * Free living to the extent that participant has control over dietary intake * Willing and able to provide written informed consent and participate in all study activities

Exclusion criteria

* Severe food allergies * Advanced kidney disease (estimated creatinine clearance \< 30 ml/min) * Known psychosis or major psychiatric illness that prevents participation with study activities * Cognitive impairment, frailty, or other disability such that individual cannot fully participate in study activities

Design outcomes

Primary

MeasureTime frameDescription
Mean Change in Nutrition as Measured by the Mediterranean Diet 14-Item Screener ScoreFrom enrollment to the end of the study at 8 monthsA slightly adapted 14-item Mediterranean diet screener was used to assess adherence to a Mediterranean-style dietary pattern. Each item was scored 0 or 1, producing a total score ranging from 0 to 14, with higher scores indicating greater adherence. The outcome, mean change in score from the beginning of exposure to the treatment to the end of the exposure to the treatment, was calculated by first subtracting each participant's score at the start of exposure from their score at the end of exposure, and then by averaging the individual changes across all participants.

Secondary

MeasureTime frameDescription
Mean Change in WeightFrom enrollment to the end of the study at 8 monthsWeight measured using a SECA 874dr scale. The outcome, mean change in weight from the beginning of exposure to the treatment to the end of the exposure to the treatment, was calculated by first subtracting each participant's weight at the start of exposure from their weight at the end of exposure, and then by averaging the individual changes across all participants.
Mean Change in Blood PressureFrom enrollment to the end of the study at 8 monthsSystolic and diastolic blood pressure was measured using an automated portable sphygmomanometer (Omron HEM-907XL, Vernon Hills, IL). Two readings were taken with a 1-minute interval and averaged by the device. The outcome, mean change in systolic and diastolic blood pressure from the beginning of exposure to the treatment to the end of the exposure to the treatment, was calculated by first subtracting each participant's blood pressure at the start of exposure from their blood pressure at the end of exposure, and then by averaging the individual changes across all participants.
Mean Change in Skin Carotenoid LevelsFrom enrollment to the end of the study at 8 monthsSkin carotenoid levels were measured using pressure-mediated spectroscopy (Veggie Meter®). Three readings were taken and averaged. Scores range from 0-800 arbitrary units with higher values indicating greater carotenoid concentrations or greater fruit and vegetable intake. The outcome, mean change in skin carotenoid level from the beginning of exposure to the treatment to the end of the exposure to the treatment, was calculated by first subtracting each participant's skin carotenoid level at the start of exposure from their skin carotenoid level at the end of exposure, and then by averaging the individual changes across all participants.
Change in Food SecurityFrom enrollment to the end of the study at 8 monthsFood security status was assessed using the validated two-item Hunger Vital Sign™ screener for the past 12 months: (1) "We worried whether our food would run out before we got money to buy more" and (2) "The food we bought just didn't last and we didn't have money to get more." Response options: Often true, Sometimes true, Never true, Don't know. Participants who selected "Often true" or "Sometimes true" for either item were categorized as "At Risk for Food Insecurity." Participants who did not select "Often true" or "Sometimes true" for either item were categorized as "Food Secure." The outcome, change in food security status from the beginning of exposure to the treatment to the end of the exposure to the treatment was tabulated by counting the number of participants that changed food security status or remained the same during the exposure to the treatment.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAlice Ammerman, PhD

University of North Carolina, Chapel Hill

Baseline characteristics

Characteristic
Age, Customized
Age group
18-29 years
14 Participants
Age, Customized
Age group
30-44 years
66 Participants
Age, Customized
Age group
45-64 years
96 Participants
Age, Customized
Age group
65 years and older
8 Participants
Blood Pressure
Diastolic
79.51 mmHg
STANDARD_DEVIATION 11.35
Blood Pressure
Systolic
120.22 mmHg
STANDARD_DEVIATION 16.52
Education
Bachelor's degree or higher
17 Participants
Education
High school or GED
12 Participants
Education
Less than high school
10 Participants
Education
Some college
19 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
22 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
42 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
6 Participants
Food Security
At Risk for Food Insecurity
15 Participants
Food Security
Food Secure
41 Participants
Income
$100,000 to $149,999
8 Participants
Income
$150,000 to $199,999
6 Participants
Income
<$20,000
7 Participants
Income
$200,000 or more
2 Participants
Income
$20,000 to $34,999
2 Participants
Income
$35,000 to $49,999
19 Participants
Income
$50,000 to $74,999
33 Participants
Income
$75,000 to $99,999
11 Participants
Mediterranean Diet Score5.79 Mediterranean Diet Score (range 0-14)
STANDARD_DEVIATION 2.35
Race/Ethnicity, Customized
Race
Alaska Native
0 Participants
Race/Ethnicity, Customized
Race
American Indian
1 Participants
Race/Ethnicity, Customized
Race
Asian
1 Participants
Race/Ethnicity, Customized
Race
Black
56 Participants
Race/Ethnicity, Customized
Race
Don't know
0 Participants
Race/Ethnicity, Customized
Race
More than one race
7 Participants
Race/Ethnicity, Customized
Race
Native Hawaiian
0 Participants
Race/Ethnicity, Customized
Race
Other
11 Participants
Race/Ethnicity, Customized
Race
Other Pacific Islander
0 Participants
Race/Ethnicity, Customized
Race
White
25 Participants
Sex: Female, Male
Female
23 Participants
Sex: Female, Male
Male
89 Participants
Skin Carotenoid Levels243.81 Carotenoid level (arbitrary units)
STANDARD_DEVIATION 75.04
Weight197.82 Pounds
STANDARD_DEVIATION 52.39

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 810 / 770 / 95
other
Total, other adverse events
0 / 810 / 770 / 95
serious
Total, serious adverse events
0 / 810 / 770 / 95

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 29, 2026